Oxypurinol
![]() | |
Names | |
---|---|
Preferred IUPAC name
1,2-Dihydropyrazolo[4,3-e]pyrimidine-4,6-dione | |
Systematic IUPAC name
1H,2H,4H,5H,6H-pyrazolo[3,4-d]pyrimidine-4,6-dione | |
Other names
1H,2H,5H-pyrazolo[3,4-d]pyrimidine-4,6-dione Alloxanthine | |
Identifiers | |
139956 | |
2465-59-0 | |
ChEBI | CHEBI:28315 |
ChEMBL | ChEMBL859 ![]() |
ChemSpider | 4483 ![]() |
EC number | 219-570-9 |
| |
Jmol-3D images | Image |
KEGG | C07599 |
MeSH | Oxypurinol |
PubChem | 4644 |
| |
UNII | G97OZE5068 |
Properties | |
C5H4N4O2 | |
Molar mass | 152.11086 |
Appearance | white crystals |
Except where noted otherwise, data is given for materials in their standard state (at 25 °C (77 °F), 100 kPa) | |
Infobox references | |
Oxypurinol is an inhibitor of xanthine oxidase. It is an active metabolite of allopurinol and it is cleared renally. In cases of renal disease, this metabolite will accumulate to toxic levels. By inhibiting xanthine oxidase, it reduces uric acid production. High serum uric acid levels may result in gout, kidney stones, and other medical conditions.